⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11007820 | 0.70 | — | — | |
| SCHEMBL3843115 | 0.63 | — | — | |
| SCHEMBL996566 | 0.60 | GSK3A (0.33) | — | |
| SCHEMBL36967 | 0.60 | — | — | |
| Hydrochloric Acid SCHEMBL5322363 | 0.58 | — | — | |
| Ethane SCHEMBL21589349 | 0.58 | GSK3A (0.32) | — | |
| SCHEMBL7025941 | 0.58 | — | — | |
| SCHEMBL28173122 | 0.56 | — | — | |
| Benzene SCHEMBL27617257 | 0.56 | GSK3B (0.31) | — | |
| SCHEMBL4739282 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020161209-A1 | Compositions inducing cleavage of RNA motifs | RIBOZYME PHARMACEUTICALS, INC. | 2002-10-31 | — | — | US | claimed |
| JP-2002510207-A | — | — | 2002-04-02 | — | — | JP | claimed |
| EP-0866865-B1 | CHIMERIC OLIGOMERS HAVING AN RNA-CLEAVAGE ACTIVITY | VIMRX HOLDINGS LTD (US) | 2002-02-06 | — | — | EP | claimed |
| US-6300483-B1 | FORM, IN COMBINATION WITH AN RNA SUBSTRATE, A STRUCTURE RESEMBLING A HAMMERHEAD STRUCTURE; ANTISENSE THERAPY | RIBOZYME PHARMACEUTICALS, INC. | 2001-10-09 | — | — | US | claimed |
| EP-1019497-A1 | HAMMERHEAD RIBOZYMES WITH EXTENDED CLEAVAGE RULE | RIBOZYME PHARMACEUTICALS, INC. (US) | 2000-07-19 | — | — | EP | claimed |
| JP-2000501284-A | — | — | 2000-02-08 | — | — | JP | claimed |
| WO-1998058057-A9 | COMPOSITIONS INDUCING CLEAVAGE OF RNA MOTIFS | INNOVIR LAB INC (US) | 1999-04-08 | — | — | WO | claimed |
| WO-1998058057-A1 | COMPOSITIONS INDUCING CLEAVAGE OF RNA MOTIFS | INNOVIR LABORATORIES, INC. (US) | 1998-12-23 | — | — | WO | claimed |
| WO-1998058058-A1 | HAMMERHEAD RIBOZYMES WITH EXTENDED CLEAVAGE RULE | RIBOZYME PHARMACEUTICALS, INC. (US) | 1998-12-23 | — | — | WO | claimed |
| EP-0866865-A1 | CHIMERIC OLIGOMERS HAVING AN RNA-CLEAVAGE ACTIVITY | Vimrx Holdings, Ltd. (US) | 1998-09-30 | — | — | EP | claimed |
| WO-1997018312-A9 | CHIMERIC OLIGOMERS HAVING AN RNA-CLEAVAGE ACTIVITY | — | 1998-08-13 | — | — | WO | claimed |
| WO-1997018312-A1 | CHIMERIC OLIGOMERS HAVING AN RNA-CLEAVAGE ACTIVITY | VIMRX HOLDINGS, LTD. (US) | 1997-05-22 | — | — | WO | claimed |
| US-20020161209-A1 | Compositions inducing cleavage of RNA motifs | RIBOZYME PHARMACEUTICALS, INC. | 2002-10-31 | — | — | US | disclosed |
| US-6441158-B1 | OLIGOPEPTIDE | MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE, INC. | 2002-08-27 | — | — | US | disclosed |
| EP-1212416-A2 | NUCLEIC ACID BASED MODULATORS OF GENE EXPRESSION | RIBOZYME PHARMACEUTICALS, INC. (US) | 2002-06-12 | — | — | EP | disclosed |
| EP-0866865-B1 | CHIMERIC OLIGOMERS HAVING AN RNA-CLEAVAGE ACTIVITY | VIMRX HOLDINGS LTD (US) | 2002-02-06 | — | — | EP | disclosed |
| WO-1998058057-A1 | COMPOSITIONS INDUCING CLEAVAGE OF RNA MOTIFS | INNOVIR LABORATORIES, INC. (US) | 1998-12-23 | — | — | WO | disclosed |
| EP-0866865-A1 | CHIMERIC OLIGOMERS HAVING AN RNA-CLEAVAGE ACTIVITY | Vimrx Holdings, Ltd. (US) | 1998-09-30 | — | — | EP | disclosed |
| WO-1997018312-A9 | CHIMERIC OLIGOMERS HAVING AN RNA-CLEAVAGE ACTIVITY | — | 1998-08-13 | — | — | WO | disclosed |
| WO-1997018312-A1 | CHIMERIC OLIGOMERS HAVING AN RNA-CLEAVAGE ACTIVITY | VIMRX HOLDINGS, LTD. (US) | 1997-05-22 | — | — | WO | disclosed |